amifostine anhydrous has been researched along with Carcinoma, Small Cell in 6 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, HS | 1 |
Han, JY | 1 |
Yu, SY | 1 |
Pyo, HR | 1 |
Kim, HY | 1 |
Cho, KH | 1 |
Lee, DH | 1 |
Kim, HT | 1 |
Lee, JS | 1 |
Garces, YI | 1 |
Okuno, SH | 1 |
Schild, SE | 1 |
Mandrekar, SJ | 1 |
Bot, BM | 1 |
Martens, JM | 1 |
Wender, DB | 1 |
Soori, GS | 1 |
Moore, DF | 1 |
Kozelsky, TF | 1 |
Jett, JR | 1 |
Johnson, PW | 1 |
Muers, MF | 1 |
Peake, MD | 1 |
Poulter, KM | 1 |
Gurney, EM | 1 |
Napp, VV | 1 |
Hepburn, PM | 1 |
Brown, JM | 1 |
Arquette, M | 1 |
Wasserman, T | 1 |
Govindan, R | 1 |
Garfield, D | 1 |
Senzer, N | 1 |
Gillenwater, H | 1 |
Socinski, M | 1 |
Meagher, RC | 1 |
Rothman, SA | 1 |
Paul, P | 1 |
Koberna, P | 1 |
Willmer, C | 1 |
Baucco, PA | 1 |
Rubin, P | 1 |
Salazar, O | 1 |
Zagars, G | 1 |
Constine, LS | 1 |
Keys, H | 1 |
Poulter, CA | 1 |
Van Ess, JD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer[NCT00006012] | Phase 1/Phase 2 | 73 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 trials available for amifostine anhydrous and Carcinoma, Small Cell
Article | Year |
---|---|
Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.
Topics: Aged; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2008 |
Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisp | 2007 |
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2001 |
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.
Topics: Amifostine; Antineoplastic Agents; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response R | 2002 |
Systemic hemibody irradiation for overt and occult metastases.
Topics: Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; C | 1985 |
1 other study available for amifostine anhydrous and Carcinoma, Small Cell
Article | Year |
---|---|
Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
Topics: Amifostine; Bone Marrow; Carcinoma, Small Cell; Cell Survival; Hematopoiesis; Hematopoietic Stem Cel | 1989 |